

How does Qulipta prevent migraines? Learn how this CGRP blocker works in your body, how long it takes, and what makes it different from other options.
If you've been prescribed Qulipta (Atogepant) — or you're considering it — you probably want to know how it actually works. The short answer: Qulipta blocks a protein in your brain called CGRP that plays a major role in triggering migraine attacks.
But let's break that down in plain English so it actually makes sense.
Qulipta belongs to a class of medications called CGRP receptor antagonists, also known as "gepants." Here's what that means:
CGRP stands for calcitonin gene-related peptide. It's a small protein (neuropeptide) that your body naturally produces. CGRP has several jobs in the body, but in people with migraines, it's a key troublemaker.
During a migraine, CGRP levels spike. When CGRP attaches to its receptors (think of them like locks that CGRP keys fit into), it triggers a chain of events:
This cascade is what turns a normal day into a migraine day.
Qulipta works by sitting in those CGRP receptors — essentially blocking the "locks" so CGRP can't attach and trigger the cascade. When CGRP can't bind to its receptors:
The result? Fewer migraine attacks. In clinical trials, patients taking Qulipta experienced significantly fewer monthly migraine days compared to placebo.
For a broader overview of Qulipta, see What Is Qulipta? Uses, Dosage, and What You Need to Know.
Qulipta doesn't work like a pain reliever that kicks in within an hour. As a preventive medication, it works gradually:
Your doctor will likely evaluate your response after about 3 months to see if Qulipta is working well for you.
Each dose of Qulipta lasts about 24 hours, which is why it's taken once daily. After you swallow the tablet:
Because the effect is tied to daily dosing, consistency matters. Taking Qulipta at the same time each day helps maintain steady levels in your bloodstream.
There are several CGRP-targeting medications available. Here's how Qulipta compares:
Medications like Aimovig (Erenumab), Ajovy (Fremanezumab), and Emgality (Galcanezumab) are also CGRP-targeting preventives, but they work differently:
Qulipta's advantage: it's a daily oral tablet. No needles, no injections. For patients who prefer pills over shots, that's a significant benefit.
Nurtec ODT is another oral gepant, but there's a key difference:
If you need a medication that can both prevent migraines and treat them when they happen, Nurtec ODT offers that dual role. If you're looking for a dedicated daily preventive, Qulipta is designed specifically for that purpose.
Older migraine preventives like Topiramate, Propranolol, and Amitriptyline were originally developed for other conditions (epilepsy, high blood pressure, depression) and found to help with migraines. Qulipta was designed from the ground up specifically for migraine prevention, targeting the CGRP pathway directly. This targeted approach generally means fewer unrelated side effects.
Qulipta works by blocking CGRP receptors in your brain, preventing the chain of events that leads to a migraine attack. It's a targeted, once-daily oral treatment that represents a newer generation of migraine prevention.
If you're interested in trying Qulipta, talk to your doctor or find a prescriber near you. Already have a prescription? Check Medfinder to find it in stock near you.
Learn more about Qulipta side effects, drug interactions, and how to save money on your prescription.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.